Silvia Maglioni

Prof. Silvia Maglioni

IUF- Leibniz Research Institute for Environmental Medicine Auf'm Hennekamp 50, 40225 Düsseldorf, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Current Biology
Verified
Journal Article
Closed access
ASAlfonso Schiavi
Alfonso Schiavi
SMSilvia Maglioni
Silvia Maglioni
Konstantinos PalikarasKonstantinos Palikaras
Konstantinos Palikaras
ASAnjumara Shaik
Anjumara Shaik
FSFlavie Strappazzon
Flavie Strappazzon
Natascia VenturaNatascia Ventura
Natascia Ventura

1 August 2014 in Experimental Gerontology
Verified
Journal Article
Closed access
SMSilvia Maglioni
Silvia Maglioni
ASAlfonso Schiavi
Alfonso Schiavi
ARAlessandra Runci
Alessandra Runci
ASAnjumara Shaik
Anjumara Shaik
Natascia VenturaNatascia Ventura
Natascia Ventura

1 September 2016 in Mitochondrion
Verified
Journal Article
Closed access
SMSilvia Maglioni
Silvia Maglioni
Natascia VenturaNatascia Ventura
Natascia Ventura

10 April 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KAKatarzyna Arczewska
Katarzyna Arczewska
GTGisele G. Tomazella
Gisele G. Tomazella
JLJessica M. Lindvall
Jessica M. Lindvall
HKHenok Kassahun
Henok Kassahun
SMSilvia Maglioni
Silvia Maglioni
HNHilde Loge Nilsen
Hilde Loge Nilsen
Transcription-blocking oxidative DNA damage is believed to contribute to aging and to underlie activation of oxidative stress responses and down-regulation of insulin-like signaling (ILS) in Nucleotide Excision Repair (NER) deficient mice. Here, we present the first quantitative proteomic description of the Caenorhabditis elegans NER-defective xpa-1 mutant and compare the proteome and transcriptome signatures. Both methods indicated activation of oxidative stress responses, which was substantiated biochemically by a bioenergetic shift involving increased steady-state reactive oxygen species (ROS) and Adenosine triphosphate (ATP) levels. We identify the lesion-detection enzymes of Base Excision Repair (NTH-1) and global genome NER (XPC-1 and DDB-1) as upstream requirements for transcriptomic reprogramming as RNA-interference mediated depletion of these enzymes prevented up-regulation of genes over-expressed in the xpa-1 mutant. The transcription factors SKN-1 and SLR-2, but not DAF-16, were identified as effectors of reprogramming. As shown in human XPA cells, the levels of transcription-blocking 8,5'-cyclo-2'-deoxyadenosine lesions were reduced in the xpa-1 mutant compared to the wild type. Hence, accumulation of cyclopurines is unlikely to be sufficient for reprogramming. Instead, our data support a model where the lesion-detection enzymes NTH-1, XPC-1 and DDB-1 play active roles to generate a genomic stress signal sufficiently strong to result in transcriptomic reprogramming in the xpa-1 mutant.

27 August 2019 in Aging
Verified
Journal Article
Closed access
SMSilvia Maglioni
Silvia Maglioni
DMDanielle F. Mello
Danielle F. Mello
ASAlfonso Schiavi
Alfonso Schiavi
JMJoel N. Meyer
Joel N. Meyer
Natascia VenturaNatascia Ventura
Natascia Ventura
Mild suppression of mitochondrial activity has beneficial effects across species. The nematode Caenorhabditis elegans is a versatile, genetically tractable model organism widely employed for aging studies, which has led to the identification of many of the known evolutionarily conserved mechanisms regulating lifespan. In C. elegans the pro-longevity effect of reducing mitochondrial function, for example by RNA interference, is only achieved if mitochondrial stress is applied during larval development. Surprisingly, a careful analysis of changes in mitochondrial functions resulting from such treatments during the developmental windows in which pro-longevity signals are programmed has never been carried out. Thus, although the powerful C. elegans genetics have led to the identification of different molecular mechanisms causally involved in mitochondrial stress control of longevity, specific functional mitochondrial biomarkers indicative or predictive of lifespan remain to be identified. To fill this gap, we systematically characterized multiple mitochondrial functional parameters at an early developmental stage in animals that are long-lived due to mild knockdown of twelve different mitochondrial proteins and correlated these parameters with animals' lifespan. We found that basal oxygen consumption rate and ATP-linked respiration positively correlate with lifespan extension and propose the testable hypothesis that the Bioenergetic Health Index can be used as a proxy to predict health-span outcomes.

12 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSilvia Maglioni
Silvia Maglioni
ASAlfonso Schiavi
Alfonso Schiavi
MMMarlen Melcher
Marlen Melcher
VBVanessa Brinkmann
Vanessa Brinkmann
ZLZhongrui Luo
Zhongrui Luo
Natascia VenturaNatascia Ventura
Natascia Ventura
Complex-I-deficiency represents the most frequent pathogenetic cause of human mitochondriopathies. Therapeutic options for these neurodevelopmental life-threating disorders do not exist, partly due to the scarcity of appropriate model systems to study them.Caenorhabditis elegansis a genetically tractable model organism widely used to investigate neuronal pathologies. Here, we generateC. elegansmodels for mitochondriopathies and show that depletion of complex I subunits recapitulates biochemical, cellular and neurodevelopmental aspects of the human diseases. We exploit two models,nuo-5/NDUFS1- andlpd-5/NDUFS4-depleted animals, for a suppressor screening that identifies lutein for its ability to rescue animals’ neurodevelopmental deficits. We uncover overexpression of synaptic neuroligin as an evolutionarily conserved consequence of mitochondrial dysfunction, which we find to mediate an early cholinergic defect inC. elegans. We show lutein exerts its beneficial effects by restoring neuroligin expression independently from its antioxidant activity, thus pointing to a possible novel pathogenetic target for the human disease.